Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PL02.3.A Survival and T-cell tumor reactivity in patients treated with nivolumab and bevacizumab for recurrent glioblastoma in the clinical trial CA209-9UP

Autor: S Maarup, S Skadborg, A Draghi, A Borch, B Hasselbalch, C Yde, I Svane, S Hadrup, I Christensen, I Law, J Skjoeth-Rasmussen, D Scheie, H Skovgaard Poulsen, U Lassen

Publikováno v: Neuro-Oncology. 24:ii2-ii3

Background Glioblastoma (GBM) is an aggressive brain tumor with a median survival of 14.6 months. We have no standard treatment for relapse and current treatment options have limited effect. Novel treatments are necessary to improve survival and qual

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::feb26fe7c429368b3f6fcc56111499c4
https://doi.org/10.1093/neuonc/noac174.006

Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab.

Autor: Jensen C; Nordic Bioscience A/S, Herlev, Denmark., Maarup S; The DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Poulsen HS; The DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Hasselbalch B; The DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Karsdal M; Nordic Bioscience A/S, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy, CCIT-DK, Copenhagen University Hospital, Herlev, Denmark.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Lassen U; The DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Willumsen N; Nordic Bioscience A/S, Herlev, Denmark. nwi@nordicbio.com.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Nov 05. Date of Electronic Publication: 2024 Nov 05.